(Q41818623)

12 October 2017

0 references

Modulation of the renin-angiotensin system and retinopathy (English)

1 reference

12 October 2017

Chaturvedi N

1

1 reference

PMCID

1766540

12 October 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

12 October 2017

1 reference

12 October 2017

84 Suppl 1

1 reference

12 October 2017

i29-31:discussion i50

1 reference

Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study.

12 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766540

Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats

6 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766540

Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus.

6 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766540

Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive Type 1 (insulin-dependent) diabetic patients with background retinopathy

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10956318

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10956318

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/HEART.84.SUPPL_1.I29

1 reference

12 October 2017

1 reference

12 October 2017

1 reference

PMCID

1766540